Ledger.Open graph →
SEC Form D · Amendment · filed July 24, 2015

EFFECTOR THERAPEUTICS, INC

Offering
$57.0M
Sold
$36.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (19)

Stephen T. Worland, Ph.D · San Diego, CAExec · DirectorSimeon T. George · San Diego, CADirectorJonathan T. Root · San Diego, CADirectorMarkus T. Goebel · San Diego, CADirectorKen T. Haas · San Diego, CADirectorAlana T. Mcnulty · San Diego, CAExecLaurence T. Lasky · San Diego, CADirectorRyan M. Gee · CHICAGO, ILDirectorStephen A. Zabawa · CHICAGO, ILDirectorKriss E. Spradley · CHICAGO, ILExecErik S. Nelson · CHICAGO, ILDirectorStevan Rosenberg · Farmington Hills, MIExec · DirectorHenry C. Hansel · CHICAGO, ILExec · DirectorRaymond T. Kish · CHICAGO, ILExec · DirectorAndrew J. Bresolin · CHICAGO, ILDirectorAmanda J. Forbes · HAMILTON, BermudaDirectorJohn G. Neal · HAMILTON, BermudaDirectorThomas J. Bladek · Easton, CTDirectorWilliam J. Duggan · Glastonbury, CTDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗